A patient has a suspicious lesion in their lung. To determine whether it is lung cancer, doctors want to examine a sample of tissue. But this takes time and is not always possible. Sometimes a patient is too frail to undergo the procedure. In other cases, tissue is collected, but the results do not provide enough clarity. The patient may then have to undergo the same invasive procedure again, sometimes more than once.
Researchers at Catharina Hospital and TU/e are investigating whether there is another way. By combining blood tests with information from CT scans, they hope to detect lung cancer more accurately and at an earlier stage, particularly in patients for whom a conventional biopsy is difficult or impossible. Their initial results are promising. PhD candidate Hao Cao (29) recently received an international ESMO Merit Award for this work at the ESMO Congress in Madrid, one of the world's leading scientific conferences on cancer.
Blood tests and scans complementing each other
During a biopsy, a doctor removes a small sample of tissue to check for the presence of cancer cells. This can be done, for example, by examining the airways using an endoscope or by inserting a needle through the chest wall to collect tissue. However, the procedure takes time, can be burdensome for patients and does not always provide a conclusive result.
Cao, who works at the General Clinical Laboratory of Catharina Hospital, has been investigating for some time whether blood tests can help. Certain substances in the blood can indicate the presence of cancer. These substances are known as tumor markers.
"Using blood tests alone, we were able to identify around 62 per cent of patients with lung cancer," Cao explains. "That is useful information, but it also means we still miss a proportion of patients. So we started looking at whether we could improve that figure by adding other information."
More information
Visit the website.